Sign In
Buy DOCS
$20.91
-0.330 (-1.55%)
At Close: Jul 31, 2026
Doximity (DOCS) Laps the Stock Market: Here's Why
07:16pm, Monday, 27'th Jul 2026
Doximity (DOCS) concluded the recent trading session at $20.99, signifying a +2.79% move from its prior day's close.
California Public Employees Retirement System Raises Stock Holdings in Doximity, Inc. $DOCS
04:13am, Monday, 27'th Jul 2026
California Public Employees Retirement System lifted its stake in shares of Doximity, Inc. (NYSE: DOCS) by 19.7% during the first quarter, according to the company in its most recent disclosure with t
Contrasting OBOOK (NASDAQ:OWLS) & Doximity (NYSE:DOCS)
01:15am, Wednesday, 22'nd Jul 2026
Doximity (NYSE: DOCS - Get Free Report) and OBOOK (NASDAQ: OWLS - Get Free Report) are both services companies, but which is the better investment? We will compare the two businesses based on the stre
Doximity (DOCS) Declines More Than Market: Some Information for Investors
07:16pm, Friday, 17'th Jul 2026
Doximity (DOCS) closed at $21.52 in the latest trading session, marking a -3.11% move from the prior day.
Reasons to Retain Doximity Stock in Your Portfolio for Now
03:26pm, Friday, 17'th Jul 2026
DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.
Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026
04:01pm, Thursday, 16'th Jul 2026
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e
Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety
02:26pm, Wednesday, 15'th Jul 2026
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, o
Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investors
07:16pm, Friday, 10'th Jul 2026
In the closing of the recent trading day, Doximity (DOCS) stood at $21.77, denoting a -1.09% move from the preceding trading day.
Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders?
12:32pm, Friday, 03'rd Jul 2026
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible
Doximity: Everyone Is Focused On The Guidance While Missing The Valuation And AI Stories
05:33am, Tuesday, 30'th Jun 2026
Doximity issued conservative FY2027 guidance, projecting 4% revenue growth and a 49% adjusted EBITDA margin, triggering a post-earnings stock selloff. I view the selloff as a temporary dislocation and
Doximity's AI Expansion Raises Execution Risks: Analyst
01:46pm, Monday, 29'th Jun 2026
Bank of America Securities (BofA) on Monday downgraded Doximity Inc. (NYSE:DOCS), citing limited clarity on the trajectory of revenue/margins.
Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:15pm, Thursday, 25'th Jun 2026
Doximity (DOCS) concluded the recent trading session at $19.85, signifying a -4.7% move from its prior day's close.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS
10:00am, Thursday, 25'th Jun 2026
NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). Such investors are advised to conta
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS
05:43pm, Tuesday, 23'rd Jun 2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advi
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS
10:00am, Thursday, 18'th Jun 2026
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). Such investors are advised to conta
